Understanding Your Wegovy vs Mounjaro Treatment Options
Prescription Weight Loss: Wegovy vs Mounjaro Mechanisms
When comparing Wegovy vs Mounjaro for prescription weight loss, the fundamental difference lies in their hormonal targets. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone, helping to reduce appetite and promote satiety after smaller meals. This prescription-only medicine works by targeting brain appetite centres, potentially reducing food cravings and supporting long-term weight management goals.
Mounjaro takes a different approach with tirzepatide, functioning as a dual-hormone agonist targeting both GLP-1 and GIP receptors. This dual mechanism may offer additional metabolic benefits, though both treatments require administration alongside a reduced-calorie diet and increased physical activity. The Wegovy vs Mounjaro decision ultimately depends on individual patient factors that our clinical team at EverydayMeds can help evaluate during your assessment.
Wegovy vs Mounjaro Pricing: UK Treatment Costs
Understanding the investment in prescription weight loss treatment is crucial when weighing Wegovy vs Mounjaro options. Wegovy pricing at EverydayMeds starts at £79.99 for the 0.25mg starter pen, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. New customers can apply code FIRST40 at checkout, whilst returning customers benefit from code DOSE25 to reach these competitive prices.
For those seeking extended supply security, our bundle options provide convenience without multiple orders. The Intro Trio bundle (0.25mg, 0.5mg, 1mg) costs £299.99, covering your first three months of dose escalation, whilst the Ultimate Stability Trio offers three 2.4mg maintenance pens for £649.99. Both Wegovy and Mounjaro are available through our GPhC-registered pharmacy (#9012878), allowing your prescriber to recommend the most cost-effective option based on your treatment response.
Clinical Evidence: Wegovy vs Mounjaro Research Data
The clinical foundation for Wegovy vs Mounjaro comparison draws from robust trial programmes, though direct head-to-head studies remain limited. In the STEP clinical trials, patients taking Wegovy alongside diet and exercise achieved an average weight reduction of approximately 15% at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The STEP programme also demonstrated sustained benefits, with STEP 5 showing 15.2% average weight loss maintained at two years.
Mounjaro's evidence comes from the SURMOUNT trial series, utilising different patient populations and study designs that make direct comparison challenging. Both medications function as prescription-only medicines requiring clinical supervision and regular monitoring. When evaluating Wegovy vs Mounjaro options, your prescriber will consider your individual medical history, weight loss goals, and tolerance factors rather than relying solely on trial averages.
How Wegovy Works in Prescription Weight Loss
Wegovy's mechanism centres on mimicking GLP-1, a hormone naturally released by your intestines after eating to signal fullness to your brain. This prescription-only medicine binds to GLP-1 receptors in appetite control centres, potentially reducing hunger signals and extending the feeling of satisfaction after meals. The treatment may also slow gastric emptying, meaning food stays in your stomach longer, contributing to prolonged satiety. Beyond appetite regulation, Wegovy can influence reward pathways in the brain associated with food cravings, particularly for high-calorie foods. Clinical studies suggest these combined effects support sustainable weight management when used alongside lifestyle modifications. The weekly injection schedule helps maintain consistent hormone levels, providing steady appetite control throughout your treatment period.
Starting Your Wegovy vs Mounjaro Journey
Beginning prescription weight loss treatment through EverydayMeds involves a streamlined three-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers review your submission within three working days (or 24 hours with express service), determining suitability for either Wegovy or Mounjaro based on your individual profile. Once approved, your chosen treatment ships via next-day delivery in temperature-controlled packaging, ensuring medication integrity from our pharmacy to your door. The assessment process considers factors like BMI, existing health conditions, previous weight loss attempts, and medication preferences to inform the Wegovy vs Mounjaro recommendation. Our clinical team remains available throughout your treatment journey, supporting dose adjustments and addressing any concerns that arise during your weight management programme.
Wegovy vs Mounjaro Storage and Practical Considerations
Practical aspects often influence the Wegovy vs Mounjaro decision, particularly around storage and travel requirements. Wegovy pens require refrigeration at 2-8°C before first use but offer superior portability, remaining stable at room temperature (below 30°C) for up to six weeks once removed from refrigeration. This storage advantage over Mounjaro's 21-day room temperature limit makes Wegovy particularly suitable for frequent travellers or those with varying refrigeration access. Both treatments utilise pre-filled injection pens designed for weekly self-administration, though the FlexTouch system used by Wegovy has been extensively tested for user-friendliness. The dose escalation schedule for Wegovy follows a structured 16-week progression from 0.25mg to the 2.4mg maintenance dose, allowing your body to gradually adapt to the medication. Understanding these practical differences helps inform your Wegovy vs Mounjaro choice based on lifestyle compatibility.
Prescription Weight Loss Success: Wegovy vs Mounjaro Patient Profiles
The decision between Wegovy vs Mounjaro often depends on individual patient characteristics that influence treatment response and tolerability. Wegovy's established GLP-1 mechanism suits patients seeking proven weight loss support with extensive long-term safety data, particularly those who've struggled with appetite control and emotional eating patterns. The medication's cardiovascular benefits, demonstrated in the SELECT trial with a 20% reduction in major cardiovascular events, make it particularly relevant for patients with weight-related heart disease risk factors.
Mounjaro's dual-hormone approach may appeal to patients with concurrent metabolic concerns or those requiring additional glycaemic control beyond weight management. Both medications require commitment to lifestyle changes, but the Wegovy vs Mounjaro choice should align with your medical history, treatment goals, and practical preferences. Our clinical team evaluates these factors during assessment, ensuring your prescription weight loss journey begins with the most appropriate medication for your circumstances.
Secure Your Wegovy vs Mounjaro Treatment Today
Don't let indecision delay your weight management journey—both Wegovy and Mounjaro represent evidence-based prescription weight loss solutions available through EverydayMeds' expert clinical service. New customers can access treatment from £79.99 using code FIRST40 at checkout, whilst returning patients benefit from code DOSE25 for continued savings. Our three-minute assessment connects you with qualified prescribers who can definitively recommend between Wegovy vs Mounjaro based on your individual needs rather than generic comparisons. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and take the first step towards sustainable weight management. With next-day delivery and ongoing clinical support, your prescription weight loss treatment can begin as early as tomorrow.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
